Profil bibliographique

Sarah L. Buchan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

48Publications signalées

2675Citations signalées

0Affiliations récentes

Domaines associés

Immunotherapy and Immune ResponsesImmune Cell Function and InteractionT-cell and B-cell ImmunologyCancer Immunotherapy and BiomarkersCAR-T cell therapy research

Publications récentes

2025 datasetOpenAlex

Evaluation of a laboratory test called QuantiFERON Cytomegalovirus in allogeneic stem cells transplant patients to assess its ability to detect the timing when the patients' immune system can control cytomegalovirus infection, thus allowing the clinical team the discontinuation of antiviral prophylaxis

Emanuela Pelosi, Sarah L. Buchan

0 citationshttp://isrctn.com/

Accès ouvert 2024 articleOpenAlex

CTLA-4: Checkpoints beyond the membrane

Sarah L. Buchan

8 citationsMolecular Therapy

Accès ouvert 2023 articleOpenAlex

Skewed perception of personal behaviour as a contributor to antibiotic resistance and underestimation of the risks

Emily Smith, Sarah L. Buchan

7 citationsPLoS ONE

Accès ouvert 2023 articleOpenAlex

Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc

Osman Dadas, Joel D. Allen, Sarah L. Buchan, Jinny Kim et autres

4 citationsFrontiers in Immunology

Accès ouvert 2023 otherOpenAlex

Table S1 from PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity

Sarah L. Buchan, Mohannad Fallatah, Stephen M. Thirdborough, Vadim Y. Taraban et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Table S2 from PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity

Sarah L. Buchan, Mohannad Fallatah, Stephen M. Thirdborough, Vadim Y. Taraban et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Figures S1-S5 from PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity

Sarah L. Buchan, Mohannad Fallatah, Stephen M. Thirdborough, Vadim Y. Taraban et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Table S2 from PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity

Sarah L. Buchan, Mohannad Fallatah, Stephen M. Thirdborough, Vadim Y. Taraban et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Figures S1-S5 from PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity

Sarah L. Buchan, Mohannad Fallatah, Stephen M. Thirdborough, Vadim Y. Taraban et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Table S1 from PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity

Sarah L. Buchan, Mohannad Fallatah, Stephen M. Thirdborough, Vadim Y. Taraban et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity

Sarah L. Buchan, Mohannad Fallatah, Stephen M. Thirdborough, Vadim Y. Taraban et autres

0 citations

Accès ouvert 2023 otherOpenAlex

Data from PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity

Sarah L. Buchan, Mohannad Fallatah, Stephen M. Thirdborough, Vadim Y. Taraban et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.